FarmaMondo News Archives

FarmaMondo To Attend Upcoming Arab Health – 2018

February 7, 2024December 17, 2017

FarmaMondo Team is pleased to inform you that also for 2018 is attending Arab Health in Dubai. Arab Health is the largest gathering of healthcare

CIS Medical Workshop around high risk Neuroblastoma management

February 7, 2024November 17, 2017

FarmaMondo has recently hosted two days of medical workshops in Saint Petersburg and Moscow on November 9th and 10th 2017, as part of its support for

FarmaMondo establishes presence in Mexico to provide direct to hospital service around supply of unlicensed medicines

April 1, 2021November 1, 2017

FarmaMondo SA announces it has established operations in Mexico to allow direct to hospital supply of unlicensed medicines, to cover spontaneous needs and our portfolio

FarmaMondo to manage access to Dinutuximab beta EUSA for patients with Neuroblastoma

April 1, 2021October 17, 2017

FarmaMondo to manage access to Qarziba® (Dinutuximab Beta) by EUSA Pharma) for patients with High Risk Neuroblastoma in Russia and CIS region

April 1, 2021October 17, 2017

FarmaMondo SA, the world’s leader in managing paid-access to unlicensed medicines, has been appointed by EUSA Pharma to exclusively distribute Qarziba® via a Managed Access

FARMAMONDO Exhibits at Expopharm 2017 in Düsseldorf

February 7, 2024September 1, 2017

Following the successful and great experience of last 2 years’ participation FarmaMondo will return again to exhibit at EXPOPHARM 2017which will be held in Düsseldorf,

FarmaMondo to expand its operations in Russia and CIS

June 18, 2020July 1, 2017

FarmaMondo is delighted to announce further expansion of its Russian operations. As of July 1st 2017 FarmaMondo Representative Office (Moscow, Russia) provides full service coverage

FARMAMONDO Exhibits at Expopharm 2016 (Munich)

February 7, 2024October 1, 2016

Following the successful experience of last year’s participation FarmaMondo will return to exhibit at EXPOPHARM 2016 which will be held in Munich, Germany from October

FarmaMondo at Early Access Programmes Conference in London

February 7, 2024October 1, 2016

FarmaMondo is proud to sponsor this unique event, Early Access Programmes Conference, held in London , UK, on 29th – 30 th November 2016. The

FarmaMondo appointed by Ideogen Pharma to Manage Access for Carmustine (Bicnu®) for Swiss market

April 1, 2021September 7, 2016

FarmaMondo SA, the world’s leader in managing paid-access to unlicensed medicines, has been appointed by Ideogen Pharma to exclusively distribute Bicnu® (Emcure) via a Managed

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".

Cookie	Duration	Description
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt.innertube::nextId	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requests	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.

Cookie	Duration	Description
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_168675207_1	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.